224 365

Cited 8 times in

Platelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis

DC Field Value Language
dc.contributor.author김자경-
dc.contributor.author유정환-
dc.contributor.author이관식-
dc.contributor.author이정일-
dc.date.accessioned2018-07-20T07:33:53Z-
dc.date.available2018-07-20T07:33:53Z-
dc.date.issued2017-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/160292-
dc.description.abstractBACKGROUND AND AIMS: Platelet-derived growth factor receptor alpha (PDGFRα) is suggested as a prognosis marker for hepatocellular carcinoma (HCC). Since PDGFRα is also known as a marker for activated hepatic stellate cells (HSCs), this study aimed to investigate whether PDGFRα expression in HCC was dependent on the background liver fibrous condition. RESULTS: Strong PDGFRα expression in the tumor lesions was associated with decreased survival after curative HCC resection. Expression of PDGFRα in the tumor correlated with increased collagen α1(I), lecithin retinol acyltransferase, and smooth muscle α-actin suggesting increased HSCs in tumor sites. The expression of PDGFRα in the tumor sites was associated neither with underlying liver fibrosis/cirrhosis nor with the expression of PDGFRα in adjacent non-tumor sites of the liver. MATERIALS AND METHODS: Patients with HCC who underwent liver resection as curative treatment were included in this study. Using liver samples of 95 patients, tissue microarray was constructed and immunohistochemical study of PDGFRα was conducted in both tumor and non-tumor sites. PDGFRα expression in tumor and matching non-tumor sites was compared. Freshly frozen liver tissue specimens of 16 HCC patients were used for gene expression analysis of PDGFRα and fibrosis related genes. CONCLUSIONS: Our results suggest that PDGFRα overexpression in HCC is a prognostic marker independent of adjacent non-tumor site liver fibrosis status.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherImpact Journals-
dc.relation.isPartOfONCOTARGET-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHBiomarkers-
dc.subject.MESHTumor-
dc.subject.MESHCarcinoma-
dc.subject.MESHHepatocellular/metabolism-
dc.subject.MESHCarcinoma-
dc.subject.MESHHepatocellular/mortality-
dc.subject.MESHCarcinoma-
dc.subject.MESHHepatocellular/pathology-
dc.subject.MESHCarcinoma-
dc.subject.MESHHepatocellular/therapy-
dc.subject.MESHFemale-
dc.subject.MESHFollow-Up Studies-
dc.subject.MESHHumans-
dc.subject.MESHImmunohistochemistry-
dc.subject.MESHLiver Cirrhosis/pathology-
dc.subject.MESHLiver Neoplasms/metabolism-
dc.subject.MESHLiver Neoplasms/mortality-
dc.subject.MESHLiver Neoplasms/pathology-
dc.subject.MESHLiver Neoplasms/therapy-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHNeoplasm Grading-
dc.subject.MESHNeoplasm Staging-
dc.subject.MESHPrognosis-
dc.subject.MESHReceptor-
dc.subject.MESHPlatelet-Derived Growth Factor alpha/genetics-
dc.subject.MESHReceptor-
dc.subject.MESHPlatelet-Derived Growth Factor alpha/metabolism-
dc.subject.MESHSurvival Analysis-
dc.titlePlatelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Internal Medicine-
dc.contributor.googleauthorJung-Hwan Yu-
dc.contributor.googleauthorJoon Mee Kim-
dc.contributor.googleauthorJa Kyung Kim-
dc.contributor.googleauthorSuk Jin Choi-
dc.contributor.googleauthorKwan Sik Lee-
dc.contributor.googleauthorJin-Woo Lee-
dc.contributor.googleauthorHye Young Chang-
dc.contributor.googleauthorJung Il Lee-
dc.identifier.doi10.18632/oncotarget.17134-
dc.contributor.localIdA00852-
dc.contributor.localIdA04610-
dc.contributor.localIdA02666-
dc.contributor.localIdA03122-
dc.relation.journalcodeJ02421-
dc.identifier.eissn1949-2553-
dc.identifier.pmid28465473-
dc.subject.keywordhepatic stellate cell-
dc.subject.keywordhepatocellular carcinoma-
dc.subject.keywordliver cirrhosis-
dc.subject.keywordliver fibrosis-
dc.subject.keywordplatelet-derived growth factor receptor α-
dc.contributor.alternativeNameKim, Ja Kyung-
dc.contributor.alternativeNameYu, Jung Hwan-
dc.contributor.alternativeNameLee, Kwan Sik-
dc.contributor.alternativeNameLee, Jung Il-
dc.contributor.affiliatedAuthorKim, Ja Kyung-
dc.contributor.affiliatedAuthorYu, Jung Hwan-
dc.contributor.affiliatedAuthorLee, Kwan Sik-
dc.contributor.affiliatedAuthorLee, Jung Il-
dc.citation.volume8-
dc.citation.number24-
dc.citation.startPage39534-
dc.citation.endPage39546-
dc.identifier.bibliographicCitationONCOTARGET , Vol.8(24) : 39534-39546, 2017-
dc.identifier.rimsid40401-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.